IQVIA Holdings Inc. is closing in on a roughly $1.1 billion takeover of Quotient Sciences, as the US clinical research group looks to expand its role in bringing new medicines to market.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
